Research ArticleOriginal Article
Open Access

Melanoma and non-melanoma skin cancer among patients who attended at King Khalid University Hospital in Riyadh, Saudi Arabia from 2007 - 2018

Khalid A. Arab, Amjad AlRuhaili, Tariq AlJohany and Reema S. AlHammad
Saudi Medical Journal July 2020, 41 (7) 709-714; DOI: https://doi.org/10.15537/smj.2020.7.25138

References

  1. ↵
    1. Alam M,
    2. Nanda S,
    3. Mittal BB,
    4. Kim NA,
    5. Yoo S
    (2011) The use of brachytherapy in the treatment of nonmelanoma skin cancer:a review. J Am Acad Dermatol 65:377–388.
    OpenUrlPubMed
  2. ↵
    1. Nguyen TH,
    2. Ho DQD
    (2002) Nonmelanoma skin cancer. Curr Treat Options Oncol 3:193–203.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Ting PT,
    2. Kasper R,
    3. Arlette JP
    (2005) Metastatic basal cell carcinoma:Report of two cases and literature review. J Cutan Med Surg 9:10–15.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Lo JS,
    2. Snow SN,
    3. Reizner GT,
    4. Mohs FE,
    5. Larson PO,
    6. Hruza GJ
    (1991) Metastatic basal cell carcinoma:Report of twelve cases with a review of the literature. J Am Acad Dermatol 24(5 Pt 1):715–719.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Macbeth AE,
    2. Grindlay DJC,
    3. Williams HC
    (2011) What's new in skin cancer?An analysis of guidelines and systematic reviews published in 2008-2009. Clin Exp Dermatol 36:453–458.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Kricker A,
    2. Armstrong BK,
    3. English DR,
    4. Heenan PJ
    (1995) Does intermittent sun exposure cause basal cell carcinoma?a case-control study in Western Australia. Int J Cancer 60:489–494.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Markovic SN,
    2. Erickson LA,
    3. Rao RD,
    4. Weenig RH,
    5. Pockaj BA,
    6. Bardia A,
    7. et al.
    (2007) Malignant melanoma in the 21st century, part 1:Epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clinic Proceedings 3:364–380.
    OpenUrl
  8. ↵
    1. Miller DL,
    2. Weinstock MA
    (1994) Nonmelanoma skin cancer in the United States:Incidence. J Am Acad Dermatol 30:774–778.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Ferlay J,
    2. Soerjomataram I,
    3. Dikshit R,
    4. Eser S,
    5. Mathers C,
    6. Rebelo M,
    7. et al.
    (2015) Cancer incidence and mortality worldwide:Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386.
    OpenUrlCrossRefPubMedWeb of Science
    1. Battistini E,
    2. Battistini S,
    3. Barachini P
    (2005) Epidemiology of melanoma and non melanoma skin cancer in the provinces of Pisa and Massa-Carrara from 1997 to 2002. Giornale Italiano di Dermatologia e Venereologia 140:33–44.
    OpenUrl
  11. ↵
    1. Staples MP,
    2. Elwood M,
    3. Burton RC,
    4. Williams JL,
    5. Marks R,
    6. Giles GG
    (2006) Non-melanoma skin cancer in Australia:The 2002 national survey and trends since 1985. Med J Aust 184:6–10.
    OpenUrlPubMedWeb of Science
  12. ↵
    1. Diepgen TL,
    2. Mahler V
    (2002) The epidemiology of skin cancer. Br J Dermatol 146(Suppl61):1–6.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Hamid O,
    2. Robert C,
    3. Daud A,
    4. Hodi FS,
    5. Hwu WJ,
    6. Kefford R,
    7. et al.
    (2013) Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med 369:134–144.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Leiter U,
    2. Garbe C
    (2008) Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv Exp Med Biol 624:89–103.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Gloster HM,
    2. Brodland DG
    (1996) The epidemiology of skin cancer. Dermatol Surg 22:217–226.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Lomas A,
    2. Leonardi-Bee J,
    3. Bath-Hextall F
    (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166:1069–1080.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Rogers HW,
    2. Weinstock MA,
    3. Feldman SR,
    4. Coldiron BM
    (2015) Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the us population 2012. JAMA Dermatol 151:1081–1086.
    OpenUrlPubMed
  18. ↵
    1. Goldstein AM,
    2. Tucker MA
    (1993) Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr Opin Oncol 5:358–363.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Marks R
    (1995) An overview of skin cancers. Cancer 75(2 Suppl):607–612.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Australian Institute of Health and Welfare
    (December, 2004) Cancer in Australia 2001, Available from: https://www.aihw.gov.au/getmedia/f35edb9c-a103-46de-9093-081ad4af7065/ca01.pdf.aspx?inline=true.
  21. ↵
    1. Australian Institute of Health and Health system expenditures on cancer and other neoplasms in Australia 2000-01
    Health system expenditures on cancer and other neoplasms in Australia 2000-01, [cited 2005 May 26], Available from: https://www.aihw.gov.au/reports/health-welfare-expenditure/health-system-expenditures-cancer-2000-01/contents/table-of-contents.
  22. ↵
    1. Boi S,
    2. Cristofolini M,
    3. Micciolo R,
    4. Polla E,
    5. Palma PD
    (2003) Epidemiology of Skin Tumors:Data from the Cutaneous Cancer Registry in Trentino, Italy. J Cutan Med Surg 7:300–305.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Levi F,
    2. Te VC,
    3. Randimbison L,
    4. Erler G,
    5. La Vecchia C
    (2001) Trends in skin cancer incidence in Vaud:An update 1976-1998. Eur J Cancer Prev 10:371–373.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Fitzpatrick D,
    2. Gavin A,
    3. Middleton R,
    4. Catney D
    (2004) Cancer in Northern Irseland 1993-2001:A Comprehensive Report (N. Ireland Cancer Registry, Queen's University Belfast, N. Ireland).
  25. ↵
    1. Ichihashi M,
    2. Naruse K,
    3. Harada S,
    4. Nagano T,
    5. Nakamura T,
    6. Suzuki T,
    7. et al.
    (1995) Trends in nonmelanoma skin cancer in Japan. Recent Results Cancer Res 139:263–273.
    OpenUrlPubMed
  26. ↵
    1. Koh D,
    2. Wang H,
    3. Lee J,
    4. Chia KS,
    5. Lee HP,
    6. Goh CL
    (2003) Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin:analysis of the Singapore Cancer Registry data 1968-97. Br J Dermatol 148:1161–1166.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Al-Maghrabi JA,
    2. Al-Ghamdi AS,
    3. Elhakeem HA
    (2004) Pattern of skin cancer in southwestern Saudi Arabia. Saudi Med J 25:776–779.
    OpenUrlPubMed
  28. ↵
    1. Takemiya M,
    2. Ohtsuka H,
    3. Miki Y
    (1990) The relationship between solar keratoses and squamous cell carcinomas among Japanese. J Dermatol 17:342–346.
    OpenUrlPubMed
  29. ↵
    1. Woodhead AD,
    2. Setlow RB,
    3. Tanaka M
    (1999) Environmental factors in nonmelanoma and melanoma skin cancer. J Epidemiol 9(6 Suppl):S102–S114.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Walder BK,
    2. Robertson MR,
    3. Jeremy D
    (1971) Skin cancer and immunosuppression. Lancet 298:1282–1283.
    OpenUrl
  31. ↵
    1. Shahi UP,
    2. Fernandes P,
    3. Shukla NK,
    4. Chander S,
    5. Rath GK
    (1989) Electron beam irradiation in treatment of skin carcinoma. Indian J Cancer 26:41–45.
    OpenUrlPubMed
    1. Dhir A,
    2. Orengo I,
    3. Bruce S,
    4. Kolbusz R V,
    5. Alford E,
    6. Goldberg L
    (1995) Basal cell carcinoma on the scalp of an indian patient. Dermatologic Surg 21:247–250.
    OpenUrl
    1. Darby SC,
    2. Scotto J,
    3. Fears TR,
    4. Fraumeni JF
    (1984) Incidence of Nonmelanoma Skin Cancer in the United States. Biometrics 40:875.
    OpenUrl
    1. Armstrong BK,
    2. Kricker A
    (1995) Skin cancer. Dermatologic Clinics 13:583–594.
    OpenUrlPubMedWeb of Science
    1. Hall HI,
    2. Miller DR,
    3. Rogers JD,
    4. Bewerse B
    (1999) Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 40:35–42.
    OpenUrlCrossRefPubMedWeb of Science
    1. Naruse K,
    2. Ueda M,
    3. Nagano T,
    4. Suzuki T,
    5. Harada S,
    6. Imaizumi K,
    7. et al.
    (1997) Prevalence of actinic keratosis in Japan. J Dermatol Sci 15:183–187.
    OpenUrlPubMed
    1. Harris RB,
    2. Griffith K,
    3. Moon TE
    (2001) Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona 1985-1996. J Am Acad Dermatol 45:528–536.
    OpenUrlCrossRefPubMedWeb of Science
    1. Mora RG,
    2. Perniciaro C
    (1981) Cancer of the skin in blacks I. A review of 163 black patients with cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology 5:535–543.
    OpenUrlPubMedWeb of Science
    1. Fleming ID,
    2. Barnawell JR,
    3. Burlison PE,
    4. Rankin JS
    (1975) Skin cancer in black patients. Cancer 35:600–605.
    OpenUrlCrossRefPubMedWeb of Science
    1. Crowley NJ,
    2. Dodge R,
    3. Vollmer RT,
    4. Seigler HF
    (1991) Malignant melanoma in black Americans. A trend toward improved survival. Arch Surg 126:1359–1364.
    OpenUrlCrossRefPubMedWeb of Science
    1. Mora RG,
    2. Burris R
    (1981) Cancer of the skin in blacks:A review of 128 patients with basal-cell carcinoma. Cancer 47:1436–1438.
    OpenUrlPubMed
    1. Budhraja SN,
    2. Pillai VC,
    3. Periyanayagam WJ,
    4. Kaushik SP,
    5. Bedi BM
    (1972) Malignant neoplasms of the skin in Pondicherry (a study of 102 cases). Indian J Cancer 9:284–195.
    OpenUrlPubMed
    1. Chakravorty RC,
    2. Dutta-Choudhuri R
    (1968) Malignant neoplasms of the skin in Eastern India. Indian J Cancer 5:133–144.
    OpenUrlPubMed
  44. ↵
    1. Paymaster JC,
    2. Talwalkar G V,
    3. Gangadharan P
    (1971) Carcinomas and malignant melanomas of the skin in Western India. J R Coll Surg Edinb 16:166–173.
    OpenUrlPubMed
  45. ↵
    1. Rosso S,
    2. Zanetti R,
    3. Martinez C,
    4. Tormo MJ,
    5. Schraub S,
    6. Sancho-Garnier H,
    7. et al.
    (1996) The multicentre south European study “Helios”II:Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 73:1447–1454.
    OpenUrlCrossRefPubMedWeb of Science
  46. ↵
    1. Rowe DE,
    2. Carroll RJ,
    3. Day CL
    (1992) Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip:Implications for treatment modality selection. J Am Acad Dermatol 26:976–990.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords